iShares MSCI South Korea ETF vs Twist Bioscience Corp — how do they compare? iShares MSCI South Korea ETF trades at $172.27, while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: Twist Bioscience Corp is trading nearer its 52-week high, iShares MSCI South Korea ETF nearer its low. Which is the better fit depends on your goals.
| EWY | TWST | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $219.20 | $124.88 |
52-Week Low | $71.22 | $24.16 |
Market Cap | — | $7.72B |
Enterprise Value | — | $7.65B |
Trailing returns across standard periods
EWY tracks the MSCI Korea 25/50 Index, offering targeted exposure to large and mid-cap companies in South Korea. It is structurally centered on the global technology supply chain, industrials, and financial services, serving as a liquid tool for investors seeking a single-country view of this advanced, innovation-led economy.
Read more on EWY →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →